Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT04119024

Conditions: Acral Melanoma, Adenocarcinoma, Adenocarcinoma of Lung, +59 more
Locations: City of Hope Duarte, California, United States

UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Stanford, California, United States

View Trial Details

Recruiting

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT04907643

Conditions: Adenocarcinoma, Ampullary Cancer, Anal Cancer, +128 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

View Trial Details

Recruiting

Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors

NCT07404176

Conditions: Metastatic Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Tata Memorial Hospital, Mumbai, India Mumbai, Maharashtra, India

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Navi Mumbai, Maharashtra, India

View Trial Details

Recruiting

The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

NCT07151391

Conditions: Gynecologic Cancer, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

18F-DOPA II - PET Imaging Optimization

NCT04706910

Conditions: Basal Ganglia Diseases, Brain Diseases, Brain Neoplasms, +36 more
Locations: WC Mackenzie Health Science Centre / University of Alberta Hospital Edmonton, Alberta, Canada

View Trial Details

Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

NCT06055439

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +17 more
Locations: Emory University Atlanta, Georgia, United States

University of Chicago Chicago, Illinois, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Recruiting

Sapu003 in Advanced mTOR-sensitive Solid Tumors

NCT07369505

Conditions: Adenocarcinoma, Breast Cancer Metastatic, Carcinoma, +40 more
Locations: SOCRU Adelaide, Australia

View Trial Details

Recruiting

F-Tryptophan PET/CT in Human Cancers

NCT05556473

Conditions: Brain Diseases, Brain Neoplasms, Breast Cancer, +27 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

NCT04373564

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +34 more
Locations: Scottsdale Medical Imaging, LLC Scottsdale, Arizona, United States

Yale University School of Medicine New Haven, Connecticut, United States

University of Chicago Medical Center Chicago, Illinois, United States

Methodist Medical Center of Illinois Peoria, Illinois, United States

View all 51 locations

View Trial Details

Recruiting

Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs

NCT06356467

Conditions: GEP-NET, Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, +5 more
Locations: IRCCS OSpedale San Raffaele Milan, Italy

View Trial Details